1Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advaneed oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996,49 (5) : 1304 - 1313. 被引量：1
2Drueke T, Witko-Sarsat V, Massy Z, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation,2002, 106 ( 17 ) :2212 - 2217. 被引量：1
4Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia: role of oxidative stress. Blood Purif,2002,20 (5) :481 -484. 被引量：1
5Descamps-Latscha B, Witko-Sarsat V. Oxidative stress in chronic renal failure and hemodialysis. Nephrologie,2003,24 ( 7 ) : 377 - 379. 被引量：1
6Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, et al. Advanced oxidation protein products as risk factors for atherosclerotie cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis,2005,45( 1 ) :39 -47. 被引量：1
7Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation [ J ]. Arterioscler Thromb Vasc Biol, 2006,26 ( 5 ) : 1156 - 1162. 被引量：1
8Shi XY, Hou FF, Niu HX, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology, 2008,149 ( 4 ) : 1829 - 1839. 被引量：1
9Li HY, Hou FF, Zhang X, et al. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol,2007,18 (2) :528 - 538. 被引量：1
10Krzystek-Korpacka M, Patryn E, Boehm D, et al. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clin Biochem, 2008,41 ( 12 ) : 943 - 949. 被引量：1
